influenza
virus
take
yearli
toll
human
life
despit
effort
contain
season
vaccin
virus
evad
human
immun
evolut
variant
resist
neutral
identif
antibodi
recogn
invari
structur
influenza
haemagglutinin
ha
protein
invigor
effort
develop
univers
influenza
vaccin
specif
antibodi
highli
conserv
stem
region
ha
neutral
divers
viral
subtyp
antibodi
larg
deriv
specif
antibodi
gene
heavychain
variabl
region
limit
affin
matur
germlin
ancestor
ha
stimul
naiv
b
cell
matur
induc
protect
immun
unknown
address
question
analys
structur
genet
basi
engag
matur
broadli
neutral
antibodi
show
germlineencod
precursor
antibodi
act
function
bcell
antigen
receptor
bcr
initi
subsequ
affin
matur
neither
germlin
precursor
prototyp
antibodi
ref
two
natur
human
antibodi
bound
ha
solubl
immunoglobul
igg
howev
three
precursor
engag
ha
antibodi
express
cell
surfac
igm
ha
trigger
bcrassoci
tyrosin
kinas
signal
germlin
transmembran
igm
recognit
viru
neutral
depend
sole
heavi
chain
affin
matur
requir
seven
amino
acid
complementaritydetermin
region
cdr
framework
region
restor
full
activ
find
provid
insight
initi
event
lead
gener
broadli
neutral
antibodi
influenza
inform
ration
design
vaccin
elicit
antibodi
provid
model
relev
infecti
diseas
includ
human
immunodefici
virusaid
data
suggest
select
immunoglobulin
gene
recogn
specif
protein
structur
pattern
provid
substrat
affin
matur
antibodi
conserv
stem
region
ha
block
membran
fusion
prevent
product
infect
divers
influenza
virus
structur
basi
ha
stem
recognit
two
monoclon
antibodi
defin
antibodi
bind
nanomolar
affin
highli
conserv
hydrophob
groov
interfac
two
polypeptid
constitut
ha
neutral
sever
influenza
group
subtyp
includ
ref
among
antistem
antibodi
isol
far
gene
segment
observ
frequent
expect
chanc
understand
develop
antibodi
studi
prototyp
broadli
neutral
antibodi
isol
phage
display
human
immunoglobulin
gene
well
two
other
clone
singl
human
cell
ref
influenza
broadli
neutral
antibodi
undergo
rel
low
degre
somat
mutat
averag
amino
acid
heavi
chain
n
fig
first
ask
whether
germlin
antibodi
precursor
might
recogn
ha
measur
affin
notabl
germlin
ancestor
fail
bind
ha
solubl
igg
even
concentr
high
mg
ml
fig
defin
molecular
basi
affin
matur
antibodi
analys
respect
contribut
heavi
light
chain
antigen
recognit
compar
chimaer
antibodi
consist
somat
heavi
sh
germlin
light
gl
chain
matur
antibodi
shsl
chimaer
shgl
three
antibodi
bound
recombin
ha
affin
similar
respect
matur
shsl
fig
matur
light
chain
thu
affect
bind
ha
rather
somat
mutat
heavi
chain
gene
alon
mediat
increas
bind
affin
find
consist
lack
lightchain
interact
observ
crystal
structur
complex
suggest
lightchain
somat
mutat
may
incident
requir
heavylightchain
pair
improv
neutral
function
next
investig
minimum
requir
heavychain
loop
matur
lead
somat
activ
chose
focu
analysi
first
antistem
broadli
neutral
antibodi
discov
structur
known
sh
differ
germlin
heavi
gh
chain
amino
acid
fig
four
amino
acid
pro
arg
ly
phe
contact
ha
stem
crystal
structur
fig
gener
sever
germlin
variant
introduc
residu
sh
includ
cdr
cdr
cdr
gh
singli
combin
result
antibodi
analys
abil
bind
ha
neutral
viru
hapseudotyp
lentivir
system
tabl
test
individu
somat
cdr
scdr
increas
bind
less
sh
furthermor
scdr
alon
confer
detect
activ
neutral
assay
tabl
although
alon
improv
potenc
germlin
scdr
togeth
restor
full
activ
bind
neutral
virus
tabl
fig
supplementari
fig
find
suggest
mutat
small
number
germlin
residu
enabl
potent
neutral
cdr
sit
adjac
one
anoth
fold
protein
examin
protein
structur
antibodi
cdr
mutat
phe
buri
canon
conform
cdr
ref
contrast
somat
mutat
cdr
flip
hydrophob
residu
phe
place
residu
contact
ha
determin
whether
posit
phe
due
matur
bind
solv
crystal
structur
unligand
shgl
compar
antibodi
mutat
cdr
haligand
fig
unligand
structur
phe
expos
surfac
suggest
somat
mutat
lead
placement
therea
hydrophob
residu
interior
antibodi
made
avail
contribut
interfac
mutat
adjac
residu
cdr
germlin
affinitymatur
state
well
order
unless
bound
antigen
howev
cdr
loop
favour
noncanon
conform
phe
expos
whether
ha
bound
solv
structur
suggest
main
consequ
somat
cdr
mutat
favour
noncanon
state
comparison
structur
also
explain
synergist
effect
mutat
cdr
somat
mutat
introduc
phe
surfac
adjac
phe
cdr
two
set
mutat
increas
hydrophob
contact
surfac
either
alon
minim
somat
mutat
germ
line
requir
confer
full
activ
made
surpris
germlin
antibodi
recogn
ha
measur
affin
solut
propos
antibodi
recognit
lowaffin
germlin
revert
requir
physiolog
present
exampl
cell
surfac
antibodi
would
normal
express
natur
bival
transmembran
igm
form
germ
line
transfect
human
embryon
kidney
cell
cell
surfac
express
confirm
stain
antilambdachain
antibodi
fluorescentlabel
ha
stain
cell
mock
transfect
cell
measur
flow
cytometri
fig
contrast
bind
seen
solut
germlin
fab
monom
bival
igg
decamer
igm
antibodi
deriv
supplementari
fig
specif
germlin
bind
ha
stem
confirm
minimum
reactiv
mutant
ha
probe
block
antistemantibodi
bind
supplementari
fig
show
similar
membranedepend
recognit
fig
result
suggest
membran
present
antibodi
provid
mechan
lowaffin
germlin
b
cell
achiev
suffici
bind
recogn
antigen
affin
matur
consist
experi
show
twodimension
confin
cluster
plasma
membran
increas
appar
affin
cell
surfac
receptor
two
amino
acid
tip
cdr
ile
phe
seem
anchor
germlin
might
attach
ha
fig
inde
mutat
two
amino
acid
alanin
abolish
ha
germlin
bind
antibodi
fig
individu
mutat
ile
phe
also
abolish
bind
unmodifiedn
ha
trimer
bind
presenc
prevent
sialic
acid
mediat
cell
adhes
fig
supplementari
fig
cocryst
structur
cdr
insert
hydrophob
pocket
ref
fig
data
suggest
interact
germlin
cdr
central
role
recognit
engag
ha
stem
determin
whether
bind
antigen
germlin
antibodi
display
cell
surfac
could
induc
bcr
activ
signal
transmembran
igm
version
germlin
transfect
transform
human
b
cell
capabl
express
function
bcr
ramo
cell
clone
whose
endogen
igm
express
method
found
proteoliposomearray
ha
supplementari
fig
select
trigger
tyrosin
phosphoryl
bcr
effector
protein
ref
fig
signal
ha
compar
induc
igm
crosslink
furthermor
mutat
cdr
abolish
respons
ha
stimul
consist
bind
data
confirm
import
germlin
cdr
structur
naiv
bcell
activ
find
indic
engag
lowaffin
germlin
antibodi
lead
bcr
activ
thu
trigger
matur
subsequ
humor
immun
respons
shown
studi
antibodi
mutat
germlineencod
vh
sequenc
engag
influenza
ha
suffici
affin
trigger
bcell
activ
case
engag
depend
membran
present
antibodi
structur
determinanttwo
specif
hydrophob
residu
cdr
mutat
analysi
reveal
mutat
convert
germlin
antibodi
full
activ
taken
togeth
result
suggest
germ
line
pois
form
vari
set
cdr
sequenc
broadli
neutral
antibodi
direct
highli
conserv
stem
influenza
ha
antibodi
inher
potenti
recogn
common
featur
influenza
viru
would
seem
offer
obviou
evolutionari
advantag
although
neutral
antibodi
virus
human
immunodefici
viru
hiv
sar
hepat
c
viru
also
use
gene
recognit
interact
differ
exampl
antibodi
bind
site
env
antibodi
bind
ref
orient
cdr
hydrophob
cleft
wherea
other
sar
neutral
antibodi
orient
cdr
hydrophil
site
case
actual
fold
recogn
cdr
distinct
recogn
ha
stem
togeth
data
suggest
cdr
motif
particularli
well
adapt
recogn
specif
protein
fold
highli
conserv
stem
divers
influenza
viru
germlin
vh
gene
although
express
part
adapt
immun
respons
may
therefor
serv
primordi
pattern
recognit
receptor
structur
adapt
particip
recognit
hydrophob
groov
heavychain
v
gene
hydrophob
cdr
ref
specul
influenza
may
exert
select
pressur
lead
retent
vh
gene
also
conceiv
adapt
immun
system
retain
innat
capac
hydrophob
contact
facilit
gener
highaffin
antibodi
limit
degre
somat
mutat
situat
contrast
consider
somat
mutat
observ
broadli
neutral
antibodi
direct
site
hiv
recent
evolv
viru
less
opportun
select
protect
antivir
gene
major
current
vaccineelicit
influenza
antibodi
direct
globular
head
region
viral
surfac
glycoprotein
ha
undergo
consider
antigen
drift
evad
human
immun
system
thu
influenza
vaccin
requir
annual
assess
strain
like
circul
come
year
gener
protect
immun
world
popul
consequ
great
interest
develop
univers
influenza
vaccin
antibodi
target
highli
conserv
ha
stem
epitop
repres
vast
major
broadli
neutral
antibodi
isol
influenza
far
previous
demonstr
possibl
elicit
stemdirect
antibodi
vaccin
despit
sequenc
variat
cdr
fr
region
antibodi
evolv
rel
small
number
somat
mutat
time
robust
induct
neutral
antibodi
human
remain
challeng
analysi
current
genom
data
genom
project
reveal
polymorph
allel
contact
site
cdr
leu
replac
phe
predict
homozyg
frequenc
gener
popul
substitut
abolish
ha
recognit
three
germlin
antibodi
supplementari
fig
find
underscor
remark
specif
cdr
contact
rais
possibl
vaccin
recipi
may
mount
respons
time
stem
antibodi
isol
deriv
vh
gene
segment
remain
possibl
individu
might
develop
respons
igg
loci
taken
togeth
knowledg
initi
engag
ha
stem
v
gene
subsequ
bcr
stimul
somat
mutat
aid
ration
design
univers
influenza
vaccin
gene
encod
wildtyp
ha
protein
anew
nc
ind
somat
mutat
infer
germlin
antibodi
synthes
somat
mutat
germlin
revert
germlin
cdr
ala
mutat
ile
phe
construct
introduc
mutat
germlin
heavi
chain
sitedirect
mutagenesi
plasmid
encod
protein
transfect
human
embryon
kidney
cell
line
isol
express
supernat
h
transfect
ha
trimer
protein
purifi
previous
describ
solubl
fab
igg
igm
antibodi
purifi
use
histrap
protein
g
igm
affin
column
respect
addit
gelexclus
chromatographi
perform
igm
sampl
ge
healthcar
purifi
antibodi
variant
mg
ml
assay
bind
nc
case
ind
enzymelink
immunosorb
assay
elisa
purifi
trimer
ha
protein
variou
antibodi
detect
peroxidaseconjug
goat
antihuman
igg
unless
otherwis
note
endpoint
dilut
determin
nonlinear
fit
doserespons
curv
use
detect
limit
background
absorb
variant
mg
ml
also
assay
neutral
pseudotyp
recombin
lentivirus
express
wildtyp
ha
correspond
neuraminidas
na
luciferas
report
gene
previous
describ
crystal
structur
shgl
fab
resolut
determin
molecular
replac
method
membran
present
antibodi
germ
line
express
membran
igm
format
cell
subject
facsbas
ha
cell
surfac
bind
assay
h
transfect
method
bcr
trigger
membran
igm
germ
line
transient
express
igmneg
ramo
b
cell
line
expos
proteoliposomearray
nc
method
activ
assess
extent
tyrosin
phosphoryl
use
py
antibodi
describ
full
method
associ
refer
avail
onlin
version
paper
